PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2148999
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2148999
Injectable Drug Delivery Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of injectable drug delivery Market
The global injectable drug delivery market is experiencing strong growth due to the increasing prevalence of chronic diseases, rising demand for convenient drug administration, and rapid development of advanced injection technologies. The global injectable drug delivery market size was valued at USD 756.22 billion in 2025. The market is projected to grow from USD 828.51 billion in 2026 to USD 1,719.94 billion by 2034, exhibiting a CAGR of 9.56% during 2026-2034. North America dominated the market with a 22.83% share in 2025, supported by advanced healthcare infrastructure and widespread adoption of innovative drug delivery technologies.
Injectable drug delivery systems enable medicines to be administered efficiently and directly into the body. The market includes conventional injectables as well as technologically advanced systems such as pre-filled syringes, auto-injectors, pen-injectors, and wearable devices. Increasing demand for self-administration, minimally invasive treatment, and patient-friendly delivery solutions is creating significant opportunities for manufacturers.
Market Definition and Scope
Injectable drug delivery refers to systems and devices used to administer therapeutic drugs through injection. These technologies are increasingly replacing conventional vial-and-syringe approaches with convenient and ready-to-use solutions. Pre-filled syringes, auto-injectors, pen-injectors, and wearable injectors help improve dosing accuracy, treatment convenience, and patient compliance.
The market covers device types, product types, end users, and regional markets, with applications across hospitals, clinics, homecare settings, and other healthcare environments. Growing demand for advanced therapies and self-administration devices is further expanding the market scope.
Market Dynamics
Drivers
The rising patient preference for ready-to-use and reusable injectable devices is a major market driver. Conventional vial-and-syringe systems can involve dosing and handling errors and may increase infection risks. Pre-filled syringes and other advanced devices offer greater convenience, accuracy, and ease of use.
Continuous research and development in drug delivery technologies is also supporting market expansion. Manufacturers are developing smart wearables, needle-free injectors, advanced syringes, and connected devices to improve treatment delivery. Increasing prevalence of diabetes, cancer, autoimmune disorders, and other chronic diseases is further increasing demand.
Trends
Strong mergers, acquisitions, and strategic partnerships are contributing to product innovation. Pharmaceutical and medical device companies are increasingly focusing on sterile packaging, pre-filled systems, wearable injectors, and convenient drug delivery technologies.
The growing adoption of wearable and self-administration devices is another important trend, particularly as patients increasingly seek convenient treatment options outside hospitals and clinics.
Restraints
The high cost of advanced injectable devices and active therapies can limit adoption, particularly in emerging economies. Limited reimbursement coverage and high out-of-pocket healthcare expenditure also encourage patients to continue using traditional injectable products rather than advanced delivery systems.
Impact of COVID-19
COVID-19 created both opportunities and challenges for the injectable drug delivery market. Increased demand for injections, pre-filled syringes, and medical supplies encouraged manufacturers to increase production capacity. Supply-chain disruptions affected certain systems, while the pandemic also accelerated research into smart wearables and technologies supporting remote healthcare and patient monitoring.
Segmentation Analysis
By device type, the market includes conventional injectables, pre-filled syringes, auto-injectors, pen-injectors, and wearable devices. Conventional injectables held the largest market share in 2025, supported by widespread use in hospitals, surgeries, infectious disease treatment, and immunization programs.
By product type, the market is divided into freeze-dried products and injectable sterile products. Injectable sterile products dominated the market due to their quality, storability, and lower infection risk. Freeze-dried products are expected to witness faster growth because they support drug stability and bioavailability.
By end user, the market includes hospitals, clinics, homecare settings, and others. Hospitals remain dominant, while homecare settings are expected to experience significant growth as patients increasingly shift toward convenient treatment at home.
Regional Insights
North America dominated the market with a regional value of USD 172.67 billion in 2025, supported by advanced healthcare infrastructure, strong regulatory frameworks, chronic disease prevalence, and adoption of self-administration technologies.
Europe represented a significant market share due to established healthcare infrastructure, biologics adoption, and growing demand for patient-centric injectable solutions.
Asia Pacific is projected to register the highest growth rate, driven by increasing healthcare expenditure, expanding patient populations, improved healthcare access, and growing adoption of advanced injectable systems.
Latin America is witnessing steady development as healthcare infrastructure improves and access to advanced therapies expands.
Middle East & Africa offer growth opportunities through healthcare modernization, increasing healthcare expenditure, and expanding specialized treatment facilities.
Competitive Landscape
The market is competitive, with major companies focusing on advanced products, strong distribution networks, and innovative drug delivery technologies. Key players include BD, SHL Medical AG, Schott AG, West Pharmaceutical Services, Pfizer Inc., Insulet Corporation, Elcam Medical, Eli Lilly and Company, Ypsomed AG, Gerresheimer AG, and Baxter International Inc.
Key Industry Developments
Major developments include BD's successful clinical trial of the BD Libertas Wearable Injector, TEVA's launch of the AJOVY auto-injector, BD's launch of the BD Intevia two-step disposable auto-injector, and Hikma Pharmaceuticals' launch of new pre-fillable syringes in the U.S.
Report Coverage
The report provides comprehensive analysis of the injectable drug delivery market, covering market size, market value, device types, product types, end users, regional markets, market trends, growth drivers, restraints, competitive landscape, and key industry developments. It also evaluates technological innovations and factors influencing the adoption of advanced injectable drug delivery systems.
Conclusion
The global injectable drug delivery market is projected to expand from USD 756.22 billion in 2025 to USD 828.51 billion in 2026 and reach USD 1,719.94 billion by 2034. Rising chronic disease prevalence, increasing patient preference for convenient self-administration, continuous R&D, and growing adoption of pre-filled, wearable, and smart injectable devices will support long-term market growth. North America remains a leading market, while Asia Pacific is expected to provide significant future growth opportunities.
Unit Value (USD Billion)
By Device Type
- Conventional Injectable
- Pre-filled Syringes
- Auto-injectors
- Pen-injectors
- Wearable
By Product Type
- Freeze-dried Products
- Injectable Sterile Products
By End User
- Hospitals
- Home Care Settings
- Clinics
- Others
By Geography
- North America (the USA, and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
- Latin America (Brazil, Mexico and the Rest of the Latin America)
- Middle East & Africa (South Africa, GCC and the Rest of the Middle East & Africa)
Table of Content
1. Introduction
- 1.1. Market Scope
- 1.2. Market Segmentation
- 1.3. Market Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Prevalence of Key Diseases - For Key Countries, 2025
- 4.2. New Product Launch
- 4.3. Overview of Technological Advancements In Injectable Drug Delivery Devices
- 4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships
5. Global Injectable Drug Delivery Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast - By Device Type
- 5.2.1. Conventional Injectables
- 5.2.2. Pre-filled Syringes
- 5.2.3. Auto-injectors
- 5.2.4. Pen-injectors
- 5.2.5. Wearable
- 5.3. Market Analysis, Insights and Forecast - By Product Type
- 5.3.1. Freeze-dried Products
- 5.3.2. Injectable Sterile Products
- 5.4. Market Analysis, Insights and Forecast - By End User
- 5.4.1. Hospitals
- 5.4.2. Homecare Settings
- 5.4.3. Clinics
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - By Geography
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Injectable Drug Delivery Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast - By Device Type
- 6.2.1. Conventional Injectables
- 6.2.2. Pre-filled Syringes
- 6.2.3. Auto-injectors
- 6.2.4. Pen-injectors
- 6.2.5. Wearable
- 6.3. Market Analysis, Insights and Forecast - By Product Type
- 6.3.1. Freeze-dried Products
- 6.3.2. Injectable Sterile Products
- 6.4. Market Analysis, Insights and Forecast - By End User
- 6.4.1. Hospitals
- 6.4.2. Homecare Settings
- 6.4.3. Clinics
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Injectable Drug Delivery Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast - By Device Type
- 7.2.1. Conventional Injectables
- 7.2.2. Pre-filled Syringes
- 7.2.3. Auto-injectors
- 7.2.4. Pen-injectors
- 7.2.5. Wearable
- 7.3. Market Analysis, Insights and Forecast - By Product Type
- 7.3.1. Freeze-dried Products
- 7.3.2. Injectable Sterile Products
- 7.4. Market Analysis, Insights and Forecast - By End User
- 7.4.1. Hospitals
- 7.4.2. Homecare Settings
- 7.4.3. Clinics
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia Pacific Injectable Drug Delivery Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast - By Device Type
- 8.2.1. Conventional Injectables
- 8.2.2. Pre-filled Syringes
- 8.2.3. Auto-injectors
- 8.2.4. Pen-injectors
- 8.2.5. Wearable
- 8.3. Market Analysis, Insights and Forecast - By Product Type
- 8.3.1. Freeze-dried Products
- 8.3.2. Injectable Sterile Products
- 8.4. Market Analysis, Insights and Forecast - By End User
- 8.4.1. Hospitals
- 8.4.2. Homecare Settings
- 8.4.3. Clinics
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America Injectable Drug Delivery Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast - By Device Type
- 9.2.1. Conventional Injectables
- 9.2.2. Pre-filled Syringes
- 9.2.3. Auto-injectors
- 9.2.4. Pen-injectors
- 9.2.5. Wearable
- 9.3. Market Analysis, Insights and Forecast - By Product Type
- 9.3.1. Freeze-dried Products
- 9.3.2. Injectable Sterile Products
- 9.4. Market Analysis, Insights and Forecast - By End User
- 9.4.1. Hospitals
- 9.4.2. Homecare Settings
- 9.4.3. Clinics
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa Injectable Drug Delivery Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast - By Device Type
- 10.2.1. Conventional Injectables
- 10.2.2. Pre-filled Syringes
- 10.2.3. Auto-injectors
- 10.2.4. Pen-injectors
- 10.2.5. Wearable
- 10.3. Market Analysis, Insights and Forecast - By Product Type
- 10.3.1. Freeze-dried Products
- 10.3.2. Injectable Sterile Products
- 10.4. Market Analysis, Insights and Forecast - By End User
- 10.4.1. Hospitals
- 10.4.2. Homecare Settings
- 10.4.3. Clinics
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2025)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis - Major Players
- 11.5. Company Profiles
- 11.5.1. BD
- 11.5.1.1. Overview,
- 11.5.1.2. Product Type& Services,
- 11.5.1.3. SWOT Analysis,
- 11.5.1.4. Recent Developments,
- 11.5.1.5. Strategies,
- 11.5.1.6. Financials (Based on Availability)
- 11.5.2. SHL Group
- 11.5.2.1. Overview,
- 11.5.2.2. Product Type& Services,
- 11.5.2.3. SWOT Analysis,
- 11.5.2.4. Recent Developments,
- 11.5.2.5. Strategies,
- 11.5.2.6. Financials (Based on Availability)
- 11.5.3. Schott AG
- 11.5.3.1. Overview,
- 11.5.3.2. Product Type& Services,
- 11.5.3.3. SWOT Analysis,
- 11.5.3.4. Recent Developments,
- 11.5.3.5. Strategies,
- 11.5.3.6. Financials (Based on Availability)
- 11.5.4. West Pharmaceutical Services, Inc.
- 11.5.4.1. Overview,
- 11.5.4.2. Product Type& Services,
- 11.5.4.3. SWOT Analysis,
- 11.5.4.4. Recent Developments,
- 11.5.4.5. Strategies,
- 11.5.4.6. Financials (Based on Availability)
- 11.5.5. Pfizer Inc.
- 11.5.5.1. Overview,
- 11.5.5.2. Product Type& Services,
- 11.5.5.3. SWOT Analysis,
- 11.5.5.4. Recent Developments,
- 11.5.5.5. Strategies,
- 11.5.5.6. Financials (Based on Availability)
- 11.5.6. Insulet Corporation
- 11.5.6.1. Overview,
- 11.5.6.2. Product Type& Services,
- 11.5.6.3. SWOT Analysis,
- 11.5.6.4. Recent Developments,
- 11.5.6.5. Strategies,
- 11.5.6.6. Financials (Based on Availability)
- 11.5.7. Elcam Medical
- 11.5.7.1. Overview,
- 11.5.7.2. Product Type& Services,
- 11.5.7.3. SWOT Analysis,
- 11.5.7.4. Recent Developments,
- 11.5.7.5. Strategies,
- 11.5.7.6. Financials (Based on Availability)
- 11.5.8. Eli Lilly and Company
- 11.5.8.1. Overview,
- 11.5.8.2. Product Type& Services,
- 11.5.8.3. SWOT Analysis,
- 11.5.8.4. Recent Developments,
- 11.5.8.5. Strategies,
- 11.5.8.6. Financials (Based on Availability)
- 11.5.9. West Pharmaceutical Services, Inc.
- 11.5.9.1. Overview,
- 11.5.9.2. Product Type& Services,
- 11.5.9.3. SWOT Analysis,
- 11.5.9.4. Recent Developments,
- 11.5.9.5. Strategies,
- 11.5.9.6. Financials (Based on Availability)
- 11.5.10. Ypsomed AG
- 11.5.10.1. Overview,
- 11.5.10.2. Product Type& Services,
- 11.5.10.3. SWOT Analysis,
- 11.5.10.4. Recent Developments,
- 11.5.10.5. Strategies,
- 11.5.10.6. Financials (Based on Availability)
- 11.5.11. Gerresheimer AG
- 11.5.11.1. Overview,
- 11.5.11.2. Product Type& Services,
- 11.5.11.3. SWOT Analysis,
- 11.5.11.4. Recent Developments,
- 11.5.11.5. Strategies,
- 11.5.11.6. Financials (Based on Availability)
- 11.5.12. Baxter International Inc
- 11.5.12.1. Overview,
- 11.5.12.2. Product Type& Services,
- 11.5.12.3. SWOT Analysis,
- 11.5.12.4. Recent Developments,
- 11.5.12.5. Strategies,
- 11.5.12.6. Financials (Based on Availability)
- 11.5.13. Other Prominent Players
- 11.5.13.1. Overview,
- 11.5.13.2. Product Type& Services,
- 11.5.13.3. SWOT Analysis,
- 11.5.13.4. Recent Developments,
- 11.5.13.5. Strategies,
- 11.5.13.6. Financials (Based on Availability)
- 11.5.1. BD
12. Strategic Recommendations
List of Tables
- Table 1: Global Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by Device Type, 2015-2026
- Table 2: Global Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by Product Type, 2015-2026
- Table 3: Global Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by End-user, 2015-2026
- Table 4: Global Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by Region, 2021-2034
- Table 5: North America Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by Device Type, 2021-2034
- Table 6: North America Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by Product Type, 2021-2034
- Table 7: North America Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
- Table 8: North America Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, By Country, 2021-2034
- Table 9: Europe Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by Device Type, 2021-2034
- Table 10: Europe Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by Product Type, 2021-2034
- Table 11: Europe Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
- Table 12: Europe Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034
- Table 13: Asia Pacific Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by Device Type, 2021-2034
- Table 14: Asia Pacific Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by Product Type, 2021-2034
- Table 15: Asia Pacific Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
- Table 16: Asia Pacific Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034
- Table 17: Latin America Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by Device Type, 2021-2034
- Table 18: Latin America Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by Product Type, 2021-2034
- Table 19: Latin America Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
- Table 20: Latin America Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034
- Table 21: Middle East & Africa Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by Device Type, 2021-2034
- Table 22: Middle East & Africa Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by Product Type, 2021-2034
- Table 23: Middle East & Africa Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, by End-user, 2021-2034
- Table 24: Middle East & Africa Injectable Drug Delivery Market Revenue (US$ Bn) Forecast, By Country/ Sub-region, 2021-2034
List of Figures
- Figure 1: Global Injectable Drug Delivery Market Revenue Breakdown (US$ Bn, %) by Region, 2025 and 2034
- Figure 2: Global Injectable Drug Delivery Market Value Share (%), by Device Type, 2025 and 2034
- Figure 3: Global Injectable Drug Delivery Market Forecast (US$ Bn), by Conventional Injectable, 2021-2034
- Figure 4: Global Injectable Drug Delivery Market Forecast (US$ Bn), by Pre-Filled Syringes, 2021-2034
- Figure 5: Global Injectable Drug Delivery Market Forecast (US$ Bn), by Auto-injectors, 2021-2034
- Figure 6: Global Injectable Drug Delivery Market Forecast (US$ Bn), by Pen-injectors, 2021-2034
- Figure 7: Global Injectable Drug Delivery Market Forecast (US$ Bn), by Wearable, 2021-2034
- Figure 8: Global Injectable Drug Delivery Market Value Share (%), by Product Type, 2025 and 2034
- Figure 9: Global Injectable Drug Delivery Market Forecast (US$ Bn), by Freeze-dried Products, 2021-2034
- Figure 10: Global Injectable Drug Delivery Market Forecast (US$ Bn), by Injectable Sterile Products, 2021-2034
- Figure 11: Global Injectable Drug Delivery Market Value Share (%), by End-user, 2025 and 2034
- Figure 12: Global Injectable Drug Delivery Market Forecast (US$ Bn), by Hospitals, 2021-2034
- Figure 13: Global Injectable Drug Delivery Market Forecast (US$ Bn), by Homecare Settings, 2021-2034
- Figure 14: Global Injectable Drug Delivery Market Forecast (US$ Bn), by Clinics, 2021-2034
- Figure 15: Global Injectable Drug Delivery Market Forecast (US$ Bn), by Others, 2021-2034
- Figure 16: Global Injectable Drug Delivery Market Value (US$ Bn), by Region, 2025 and 2034
- Figure 17: North America Injectable Drug Delivery Market Value (US$ Bn), by Device Type, 2025 and 2034
- Figure 18: North America Injectable Drug Delivery Market Value Share (%), by Device Type, 2025
- Figure 19: North America Injectable Drug Delivery Market Value (US$ Bn), by Product Type, 2025 and 2034
- Figure 20: North America Injectable Drug Delivery Market Value Share (%), by Product Type, 2025
- Figure 21: North America Injectable Drug Delivery Market Value (US$ Bn), by End-user, 2025 and 2034
- Figure 22: North America Injectable Drug Delivery Market Value Share (%), by End-user, 2025
- Figure 23: North America Injectable Drug Delivery Market Value (US$ Bn), By Country, 2025 and 2034
- Figure 24: North America Injectable Drug Delivery Market Value Share (%), By Country, 2025
- Figure 25: Europe Injectable Drug Delivery Market Value (US$ Bn), by Device Type, 2025 and 2034
- Figure 26: Europe Injectable Drug Delivery Market Value Share (%), by Device Type, 2025
- Figure 27: Europe Injectable Drug Delivery Market Value (US$ Bn), by Product Type, 2025 and 2034
- Figure 28: Europe Injectable Drug Delivery Market Value Share (%), by Product Type, 2025
- Figure 29: Europe Injectable Drug Delivery Market Value (US$ Bn), by End-user, 2025 and 2034
- Figure 30: Europe Injectable Drug Delivery Market Value Share (%), by End-user, 2025
- Figure 31: Europe Injectable Drug Delivery Market Value (US$ Bn), By Country/ Sub-region, 2025 and 2034
- Figure 32: Europe Injectable Drug Delivery Market Value Share (%), By Country/ Sub-region, 2025
- Figure 33: Asia Pacific Injectable Drug Delivery Market Value (US$ Bn), by Device Type, 2025 and 2034
- Figure 34: Asia Pacific Injectable Drug Delivery Market Value Share (%), by Device Type, 2025
- Figure 35: Asia Pacific Injectable Drug Delivery Market Value (US$ Bn), by Product Type, 2025 and 2034
- Figure 36: Asia Pacific Injectable Drug Delivery Market Value Share (%), by Product Type, 2025
- Figure 37: Asia Pacific Injectable Drug Delivery Market Value (US$ Bn), by End-user, 2025 and 2034
- Figure 38: Asia Pacific Injectable Drug Delivery Market Value Share (%), by End-user, 2025
- Figure 39: Asia Pacific Injectable Drug Delivery Market Value (US$ Bn), By Country/ Sub-region, 2025 and 2034
- Figure 40: Asia Pacific Injectable Drug Delivery Market Value Share (%), By Country/ Sub-region, 2025
- Figure 41: Latin America Injectable Drug Delivery Market Value (US$ Bn), by Device Type, 2025 and 2034
- Figure 42: Latin America Injectable Drug Delivery Market Value Share (%), by Device Type, 2025
- Figure 43: Latin America Injectable Drug Delivery Market Value (US$ Bn), by Product Type, 2025 and 2034
- Figure 44: Latin America Injectable Drug Delivery Market Value Share (%), by Product Type, 2025
- Figure 45: Latin America Injectable Drug Delivery Market Value (US$ Bn), by End-user, 2025 and 2034
- Figure 46: Latin America Injectable Drug Delivery Market Value Share (%), by End-user, 2025
- Figure 47: Latin America Injectable Drug Delivery Market Value (US$ Bn), By Country/ Sub-region, 2025 and 2034
- Figure 48: Latin America Injectable Drug Delivery Market Value Share (%), By Country/ Sub-region, 2025
- Figure 49: Middle East & Africa Injectable Drug Delivery Market Value (US$ Bn), by Device Type, 2025 and 2034
- Figure 50: Middle East & Africa Injectable Drug Delivery Market Value Share (%), by Device Type, 2025
- Figure 51: Middle East & Africa Injectable Drug Delivery Market Value (US$ Bn), by Product Type, 2025 and 2034
- Figure 52: Middle East & Africa Injectable Drug Delivery Market Value Share (%), by Product Type, 2025
- Figure 53: Middle East & Africa Injectable Drug Delivery Market Value (US$ Bn), by End-user, 2025 and 2034
- Figure 54: Middle East & Africa Injectable Drug Delivery Market Value Share (%), by End-user, 2025
- Figure 55: Middle East & Africa Injectable Drug Delivery Market Value (US$ Bn), By Country/ Sub-region, 2025 and 2034
- Figure 56: Middle East & Africa Injectable Drug Delivery Market Value Share (%), By Country/ Sub-region, 2025
- Figure 57: Global Injectable Drug Delivery Market Share (%), By Company, 2025
